Company intelligence / Profile preview

David Forbes-Nixon Family Charitable Foundation

London, United Kingdom

Ownership: Private
Employees: ~1
Development stage: Other

Overview

Funds high-quality myeloma cancer research at the Institute of Cancer Research (ICR) under Dr. Martin Kaiser, investigating onset, progression, and treatment resistance in high-risk patients; supported research leading to Kaiser's promotion to Reader in Molecular Haematology.

Therapeutic areas: Oncology
Industry: Investors

Partnerships

Institute of Cancer Research (ICR)

Beyond the preview

Go deeper on David Forbes-Nixon Family Charitable Foundation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on David Forbes-Nixon Family Charitable Foundation.

Explore the full profile